- Coordinator
- Ecrin European Clinical Research Infrastructure Network, France
- Runs
- 1 September 2026 to 31 August 2030
- Status
- Running
- EU funding
- €10.0m
- Total cost
- €10.0m
- Partners
- 23 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101292607
What the project is doing
In the project's own words, from its summary on CORDIS.
In the PRISM project, professional clinical research infrastructures and service-oriented organisations will offer the paediatric clinical research community high-quality, leading-edge and coordinated TransNational Access (TNA) services for the design, planning and conduct of paediatric interventional or observational clinical studies. Services include end-to-end support for the design, planning and execution of multinational studies conducted in 3 to 6 countries in Europe and Canada (TNA1, WP1, 50% of total budget); consulting services for the planning and design of paediatric studies (TNA2, WP2) and virtual services (TNA3, WP4) on leading-edge methodologies, new trial designs (including platform trials, trials within cohorts, decentralised trials), and access to AI and digital tools, following final development and adaptation to paediatric needs (WP5).
Supported paediatric studies will be selected based on scientific excellence and public health relevance by an independent expert panel (WP3), with a two-stage procedure for the TNA1 allowing for support to the planning and design of short-listed projects between the first and second steps, thus optimising the final study protocol before execution. Training will be provided (WP7) for infrastructure staff involved in the development and provision of new services, and for the infrastructure users, i.e. paediatric research and investigation / rare diseases networks, and private or public sponsor teams.
Beyond the end of PRISM (WP6), its ambition is offering the paediatric research community coordinated services, avoiding duplication and promoting synergies, according to a mechanism agreed with all the relevant stakeholders in paediatric clinical research (infrastructures, technology providers, sponsors, investigation networks, patients) through contractual arrangements leading to a joint access mechanism.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Coordinator |
| Ainigma Technologies | Leuven | Belgium | Participant |
| European Network of Living Labs Ivzw | Sint-Joost-ten-Node | Belgium | Participant |
| Innovation Sprint | Bruxelles / Brussel | Belgium | Participant |
| Universiteit Gent | Gent | Belgium | Participant |
| Micyrn | Vancouver, British Columbia | Canada | Participant |
| Royal Institution for the Advancement of Learning Mcgill University | Montreal | Canada | Participant |
| Swiss Clinical Trial Organisation (scto) | Bern | Switzerland | Participant |
| Universitat Basel | Basel | Switzerland | Participant |
| Universitats-Kinderspital Beider Basel | Basel | Switzerland | Third party |
| Universitatsspital Basel | Basel | Switzerland | Third party |
| Masarykova univerzita | Brno | Czechia | Participant |
| Aristotelio Panepistimio Thessalonikis | Thessaloniki | Greece | Participant |
| Diadikasia Business Consulting Symvouloi Epicheiriseon Ae | Athina | Greece | Participant |
| Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston | Athina | Greece | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Libra AI Technologies ANONYMI ETAIREIA | Athens | Greece | Participant |
| Hospices Civils De Lyon | Lyon | France | Participant |
| Pedstart | Luynes | France | Participant |
| Xeeti | Nice | France | Participant |
| Universita Cattolica Del Sacro Cuore | Milano | Italy | Participant |
| European School Heads Association | Utrecht | Netherlands | Participant |
| Grampian Health Board | Aberdeen | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI